About Me
Data Scientist
Banerjee Lab
Projects
STIMULATE-ICP
The DISC Study
Publications
COVID-19
Blog
Contact
Cardiologist
Educator
News
Publications
Publicatons
Publications
JUN
16
Gender equity and cardiovascular disease: hypertensive disorders of pregnancy as an under-recognized cardiovascular risk factor
By:
Amitava Banerjee
on
JUN
16
No abstract
Read more >>
MAY
20
A heart failure program in low-income patients in Argentina (COMM-HF)
By:
Rosana Poggio
on
MAY
20
CONCLUSIONS: A home-based educational program, designed to optimize outpatient management of heart failure and led by non-medical healthcare personnel, was well-received and demonstrated feasibility for implementation in low-income patients relying solely on the Argentine public health system.
Read more >>
MAY
16
Developing prediction models for electrolyte abnormalities in patients indicated for antihypertensive therapy: evidence-based treatment and monitoring recommendations
By:
Ariel Wang
on
MAY
16
CONCLUSION: Current clinical guidelines recommend monitoring serum electrolytes after initiating antihypertensive treatment. These clinical prediction models predicted individuals' risk of electrolyte abnormalities associated with antihypertensive treatment and could be used to target closer monitoring for individuals at a higher risk, where resources are limited.
Read more >>
MAY
07
Cardiac and liver impairment on multiorgan MRI and risk of major adverse cardiovascular and liver events
By:
Edward Jackson
on
MAY
07
Cardiovascular disease and metabolic dysfunction-associated steatotic liver disease are common conditions associated with high mortality and morbidity, yet opportunities for integrated prevention are underinvestigated. We explored the association between impairment in the liver (defined by increased iron-corrected T1 (cT1) time) and/or heart (reduced left ventricular ejection fraction ≤ 50) and risk of experiencing cardiovascular- or liver-related events or all-cause mortality among 28,841 UK...
Read more >>
MAY
07
The risk of Long Covid symptoms: a systematic review and meta-analysis of controlled studies
By:
Lauren L O'Mahoney
on
MAY
07
The global evidence on the risk of symptoms of Long Covid in general populations infected with SARS-CoV-2 compared to uninfected comparator/control populations remains unknown. We conducted a systematic literature search using multiple electronic databases from January 1, 2022, to August 1, 2024. Included studies had ≥100 people with confirmed or self-reported COVID-19 at ≥28 days following infection onset, and an uninfected comparator/control group. Results were summarised descriptively and...
Read more >>
MAY
07
Characterising acute and chronic care needs: insights from the Global Burden of Disease Study 2019
By:
GBD 2019 Acute and Chronic Care Collaborators
on
MAY
07
Chronic care manages long-term, progressive conditions, while acute care addresses short-term conditions. Chronic conditions increasingly strain health systems, which are often unprepared for these demands. This study examines the burden of conditions requiring acute versus chronic care, including sequelae. Conditions and sequelae from the Global Burden of Diseases Study 2019 were classified into acute or chronic care categories. Data were analysed by age, sex, and socio-demographic index,...
Read more >>
MAY
07
Rethinking ethnicity data for precision health
By:
Shoba Poduval
on
MAY
07
No abstract
Read more >>
APR
24
COVID-19 pandemic and risk factor measurement in individuals with cardio-renal-metabolic diseases: A retrospective study in the United Kingdom
By:
Sharmin Shabnam
on
APR
24
CONCLUSIONS: Among people with major cardiometabolic conditions, there have been substantial reductions in the assessment and control of several key RFs during the pandemic. These patients will need regular monitoring in future for the prevention of complications. Our findings also highlight the need for resilient healthcare systems to ensure continuity of care and mitigate disparities in high-risk populations.
Read more >>
APR
15
The association between proton pump inhibitors and the risk of gastrointestinal bleeding in oral anticoagulants users
By:
Zixuan Wang
on
APR
15
Current evidence of whether proton pump inhibitor (PPI) reduces the risk of gastrointestinal bleeding (GIB) associated with oral anticoagulants (OACs) is limited. Propensity score-weighted cohort and case-crossover studies were conducted separately in England and Hong Kong between 2011.01.01 and 2019.12.31. In the cohort design, we compared the hazards of hospitalised GIB in OAC + PPI users with OAC only users in people with atrial fibrillation and found higher hazard of GIB in OAC + PPI users...
Read more >>
APR
12
Change in cT1 Following Interventions in MASLD: A Systematic Review and Meta-Analysis
By:
Anneli Andersson
on
APR
12
CONCLUSIONS: Evidence to date supports a significant treatment-induced reduction in cT1 as compared with minimal changes in the placebo group. Our findings could inform study designs for investigational therapies and support monitoring of treatment response in individuals with metabolic dysfunction-associated liver disease in clinical trials and clinical practice.
Read more >>
More Posts
Create your business website with
Website Builder.
Share by:
